ELISpot and FluoroSpot Assay Market is Expected to Reach $421 million | MarketsandMarkets.
04 déc. 2023 07h30 HE
|
MarketsandMarkets Research Pvt. Ltd.
Chicago, Dec. 04, 2023 (GLOBE NEWSWIRE) -- ELISpot and FluoroSpot Assay market in terms of revenue was estimated to be worth $292 million in 2023 and is poised to reach $421 million by 2028, growing...
mRNA Platform Market Research Report 2023 - Global Industry Size, Share, Trends Opportunity, and Forecast, 2028F
01 déc. 2023 06h18 HE
|
Research and Markets
Dublin, Dec. 01, 2023 (GLOBE NEWSWIRE) -- The "mRNA Platform Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2028F" report has been added to ResearchAndMarkets.com's...
North America Digital Vaccine Markets, Competition, Forecast & Opportunities Report 2023-2028 Featuring Friendslearn, Klein Buendel, Evidation Health, Atos, and oVRcome
27 nov. 2023 07h18 HE
|
Research and Markets
Dublin, Nov. 27, 2023 (GLOBE NEWSWIRE) -- The "North America Digital Vaccine Market, Competition, Forecast & Opportunities, 2018-2028" report has been added to ResearchAndMarkets.com's...
Inequitable Access Remains a Challenge in the HBV Vaccine Market Despite Increasing Healthcare Expenditure
10 nov. 2023 08h38 HE
|
Research and Markets
Dublin, Nov. 10, 2023 (GLOBE NEWSWIRE) -- The "Global Hepatitis B Virus (HBV) Vaccine Market (by End User, Composition, & Region): Insights and Forecast with Potential Impact of COVID-19...
HilleVax Reports Third Quarter 2023 Financial Results and Highlights Recent Company Progress
09 nov. 2023 16h05 HE
|
HilleVax, Inc.
BOSTON, Nov. 09, 2023 (GLOBE NEWSWIRE) -- HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, today reported financial...
Global Therapeutic Vaccines Market Analysis 2023-2028: Regulatory Complexities Slow Entry Into the ~$12 Billion-Projected Industry
06 nov. 2023 07h48 HE
|
Research and Markets
Dublin, Nov. 06, 2023 (GLOBE NEWSWIRE) -- The "Global Therapeutic Vaccines Market (2023-2028) by Product, Disease Indication, Technology, End User, and Geography, Competitive Analysis, Impact of...
HilleVax to Present at Upcoming Investor Conferences
01 nov. 2023 16h48 HE
|
HilleVax, Inc.
BOSTON, Nov. 01, 2023 (GLOBE NEWSWIRE) -- HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, today announced that it...
Global Malaria Vaccine Market Set for Remarkable Growth in the Fight Against Malaria
31 oct. 2023 08h08 HE
|
Research and Markets
Dublin, Oct. 31, 2023 (GLOBE NEWSWIRE) -- The "Malaria Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028" report has been added to ResearchAndMarkets.com's...
Global Therapeutics Vaccine Markets, Trends, Opportunities, and Forecast, 2018-2022 & 20232028F
27 oct. 2023 08h23 HE
|
Research and Markets
Dublin, Oct. 27, 2023 (GLOBE NEWSWIRE) -- The "Therapeutics Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F" report has been added to ...
Next-Generation RNA Therapeutics and Vaccines Surge: Promising Modalities and Clinical Trials Fueling Growth in the RNA Market
12 oct. 2023 05h43 HE
|
Research and Markets
Dublin, Oct. 12, 2023 (GLOBE NEWSWIRE) -- The "RNA Therapeutics Market and RNA Vaccines Market by Type of Modality, Type of Molecule, Therapeutic Areas, Route of Administration, Key Geographical...